Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Michael M. Hopkins · SciRah

Researcher profile · Semantic Scholar

Michael M. Hopkins

Share profile

Michael M. Hopkins — researcher profile on SciRah

h-index: 19
Works: 85
Citations: 1,360

Most-cited papers

The myth of the biotech revolution: An assessment of technological, clinical and organisational change
Michael M. Hopkins, Paul Martin, P. Nightingale, A. Kraft +1 more
2007260 citations Open access
Semantic Scholar
Big Pharma, little science? A bibliometric perspective on big pharma's R&D decline
Ismael Rafols, Michael M. Hopkins, J. Hoekman, Josh Siepel +3 more
2013arXiv.org145 citations Open access
Semantic Scholar
Strategic intelligence on emerging technologies: Scientometric overlay mapping
D. Rotolo, Ismael Rafols, Michael M. Hopkins, L. Leydesdorff
2013J. Assoc. Inf. Sci. Technol.81 citations Open access
Semantic Scholar
Funding Data from Publication Acknowledgments: Coverage, Uses, and Limitations
N. Grassano, D. Rotolo, Joshua R. Hutton, Frédérique Lang +1 more
2016J. Assoc. Inf. Sci. Technol.75 citations Open access
Semantic Scholar
Autoimmune disease: Patients self-treat with parasitic worms
Stephen Flowers, Michael M. Hopkins
2013Nature68 citations
Semantic Scholar
Pharmacogenetics in Europe: Barriers and Opportunities
D. Gurwitz, E. Zika, Michael M. Hopkins, S. Gaisser +1 more
2009Public Health Genomics62 citations Open access
Semantic Scholar
The hidden research system: The evolution of cytogenetic testing in the national health service
Michael M. Hopkins
200650 citations
Semantic Scholar
DNA patenting: the end of an era?
Michael M. Hopkins, S. Mahdi, P. Patel, S. Thomas
2007Nature Biotechnology48 citations
Semantic Scholar
Buying big into biotech: scale, financing, and the industrial dynamics of UK biotech, 1980-2009
Michael M. Hopkins, Philippa A. Crane, P. Nightingale, C. Baden-Fuller
201344 citations Open access
Semantic Scholar
Generative and Degenerative Interactions: Positive and Negative Dynamics of Open, User-Centric Innovation in Technology and Engineering Consultancies
Michael M. Hopkins, J. Tidd, P. Nightingale, Roger Miller
201144 citations Open access
Semantic Scholar
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.
Stuart Hogarth, Michael M. Hopkins, V. Rodríguez
2012Sociology of Health and Illness43 citations Open access
Semantic Scholar
Towards a method for evaluating technological expectations: Revealing uncertainty in gene silencing technology discourse
John J. Sung, Michael M. Hopkins
2006Technology Analysis & Strategic Management39 citations
Semantic Scholar
Strategic risk management using complementary assets: Organizational capabilities and the commercialization of human genetic testing in the UK
Michael M. Hopkins, P. Nightingale
200633 citations Open access
Semantic Scholar
The phantom menace of gene patents
S. Gaisser, Michael M. Hopkins, K. Liddell, E. Zika +1 more
2009Nature29 citations
Semantic Scholar
Sectoral Innovation Systems in Europe: Monitoring, Analysing Trends and Identifying Challenges in Biotechnology
P. Patel, A. Arundel, Michael M. Hopkins
200825 citations
Semantic Scholar
Just how difficult can it be counting up R&D funding for emerging technologies (and is tech mining with proxy measures going to be any better)?
Michael M. Hopkins, Josh Siepel
2013Technology Analysis & Strategic Management24 citations Open access
Semantic Scholar
Hospitals and innovation: Introduction to the special section
Magnus Gulbrandsen, Michael M. Hopkins, T. Thune, F. Valentin
201621 citations
Semantic Scholar
Science, the State and the City: Britain's Struggle to Succeed in Biotechnology
G. Owen, Michael M. Hopkins
201620 citations
Semantic Scholar
Moving from non-interventionism to industrial strategy: The roles of tentative and definitive governance in support of the UK biotech sector
Michael M. Hopkins, Philippa A. Crane, P. Nightingale, C. Baden-Fuller
2019Research Policy19 citations Open access
Semantic Scholar
Shares in the human genome—the future of patenting DNA
S. Thomas, Michael M. Hopkins, Max Brady
2002Nature Biotechnology19 citations Open access
Semantic Scholar
Scientometric Mapping as a Strategic Intelligence Tool for the Governance of Emerging Technologies.
D. Rotolo, Ismael Rafols, Michael M. Hopkins, L. Leydesdorff
201417 citations Open access
Semantic Scholar
DARE to be different? A novel approach for analysing diversity in collaborative research projects
Frederique Bone, Michael M. Hopkins, Ismael Rafols, J. Molas-Gallart +3 more
2020Research Evaluation16 citations Open access
Semantic Scholar
Appraising research policy instrument mixes: a multicriteria mapping study in six European countries of diagnostic innovation to manage antimicrobial resistance
Josie Coburn, Frederique Bone, Michael M. Hopkins, A. Stirling +3 more
2021Research Policy15 citations Open access
Semantic Scholar
Biomarker patents for diagnostics: problem or solution?
Michael M. Hopkins, Stuart Hogarth
2012Nature Biotechnology15 citations Open access
Semantic Scholar
Landscape review of interdisciplinary research in the UK
Anoushka Davé, Adam Krčál, Peter Kolarz, K. Nielsen +7 more
201614 citations
Semantic Scholar
Optimising 'Test and Trace' Systems: Early lessons from a comparative analysis of six countries
Joshua R. Moon, C. K. Chekar, David Barberá, G. Davey +6 more
2020Social Science Research Network12 citations
Semantic Scholar
Personalized medicine: renewing the social science research agenda.
Stuart Hogarth, Michael M. Hopkins, A. Faulkner
2012Personalized Medicine12 citations
Semantic Scholar
Continental drift? Do European clinical genetic testing laboratories have a patent problem?
J. Liddicoat, K. Liddell, A. McCarthy, Stuart Hogarth +4 more
2019European Journal of Human Genetics11 citations Open access
Semantic Scholar
A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance
D. Mott, G. Hampson, M. Llewelyn, J. Mestre-Ferrandiz +1 more
2019Applied Health Economics and Health Policy11 citations Open access
Semantic Scholar
High-Risk HPV DNA Testing and HPV-16/18 Genotyping: What Is the Clinical Application?
L. Twiggs, Michael M. Hopkins
2011Journal of Lower Genital Tract Disease8 citations
Semantic Scholar
On a Critical Path: Genomics, the Crisis of Pharmaceutical Productivity and the Search for Sustainability
Paul Martin, Michael M. Hopkins, P. Nightingale, A. Kraft
20098 citations
Semantic Scholar
Is the Biotechnology Revolution a Myth
Michael M. Hopkins, A. Kraft, Paul Martin, P. Nightingale +1 more
20077 citations Open access
Semantic Scholar
Supporting the vital role of boundary-spanning physician researchers in the advancement of medical innovation
Michael M. Hopkins, Fabien Ibanez, M. Skingle
2021Future healthcare journal6 citations Open access
Semantic Scholar
Positive and Negative Dynamics of Open Innovation
Michael M. Hopkins, J. Tidd, P. Nightingale
20136 citations
Semantic Scholar
Technological Accretion in Diagnostics
Stuart Hogarth, Michael M. Hopkins, D. Rotolo
20155 citations
Semantic Scholar
Managing Knowledge to Capture Value in Technology and Engineering Consultancies
Joe Tidd, Michael M. Hopkins
20062006 IEEE International Conference on Management of Innovation and Technology5 citations
Semantic Scholar
Do funding sources complement or substitute? Examining the impact of cancer research publications
D. Rotolo, Michael M. Hopkins, N. Grassano
2022J. Assoc. Inf. Sci. Technol.4 citations Open access
Semantic Scholar
Exploring the interdependencies of research funders in the UK
K. Shah, J. Sussex, K. Hernandez-Villafuerte, M. Garau +10 more
20144 citations Open access
Semantic Scholar
Academic Drug Discovery Units in the UK: Progress and challenges.
Michael M. Hopkins, Jorge Mestre-Ferrándiz, Phil Crane, Michael F O'Neill
2025Drug Discovery Today3 citations Open access
Semantic Scholar
DARE to be different? Applying diversity indicators to the evaluation of collaborative research projects
Frederique Bone, Michael M. Hopkins, Ismael Rafols, J. Molas-Gallart +3 more
20193 citations
Semantic Scholar
The value of structural diversity: assessing diversity for a sustainable research base
Jonathan Adams, Michael M. Hopkins, Ismael Rafols, D. Rotolo +1 more
20153 citations
Semantic Scholar
Servant Firms in Drug Discovery: a Neglected Project Based Organizational Form
Michael M. Hopkins, P. Nightingale, C. Baden-Fuller
20123 citations
Semantic Scholar
Impact of DNA patents on pharmacogenomics research and development: economic and policy issues
D. Paci, Michael M. Hopkins, E. Zika, D. Ibarreta
20103 citations Open access
Semantic Scholar
Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry: Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz; Springer-Verlag, Berlin, 2004, 178 pages, hardcover, ISBN 3-540-40717-0
Michael M. Hopkins
20043 citations
Semantic Scholar
An Examination of Technology Strategies for the Integration of Bioinformatics in Pharmaceutical R&D Processes
Michael M. Hopkins
19993 citations
Semantic Scholar
Policies to promote affordability and access across the life cycle of costly new drugs
Krista Kruja, Jorge Mestre-Ferrándiz, Michael M. Hopkins, B. Ryll +2 more
2025British medical journal2 citations Open access
Semantic Scholar
Learning from the US
G. Owen, Michael M. Hopkins
20162 citations
Semantic Scholar
Big Pharma, Little Science? A Bibliometric Perspective on Big Pharma’s R&D Decline
Ismael Rafols, J. Hoekman, Josh Siepel, P. Nightingale +3 more
20122 citations Open access
Semantic Scholar
Is primary care the right place for genetic diagnosis?
Michael M. Hopkins
2007The British journal of general practice : the journal of the Royal College of General Practitioners2 citations
Semantic Scholar
Who can “Test. Test. Test.”? The interplay between boundary work and institutions in the organisation of diagnostic testing for COVID-19
David Barberá-Tomás, J. Bates, E. Meseguer, Michael M. Hopkins
2023The Innovation1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Nightingale×11
Invite
P. Nightingale — researcher profile on SciRah
Ismael Rafols×8
Invite
Ismael Rafols — researcher profile on SciRah
D. Rotolo×8
Invite
D. Rotolo — researcher profile on SciRah
Stuart Hogarth×5
Invite
Stuart Hogarth — researcher profile on SciRah

×3

Invite

A. Kraft — researcher profile on SciRah

Invite

S. Mahdi — researcher profile on SciRah

Invite

N. Grassano — researcher profile on SciRah

Joshua R. Hutton×3

Invite

Joshua R. Hutton — researcher profile on SciRah

Invite

E. Zika — researcher profile on SciRah

Invite

S. Gaisser — researcher profile on SciRah

Invite

D. Ibarreta — researcher profile on SciRah

C. Baden-Fuller×3

Invite

C. Baden-Fuller — researcher profile on SciRah